🇺🇸 FDA
Patent

US 10323069

Senecavirus A antigens and methods of use

granted A61KA61K2039/575A61K39/12

Quick answer

US patent 10323069 (Senecavirus A antigens and methods of use) held by Regents of the University of Minnesota expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/575, A61K39/12, A61K39/125